Jw Cayman Therapeutics Co Ltd (2126)

Hong Kong
Currency in HKD
2.11
-0.19(-8.26%)
Closed
2126 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
2.082.30
52 wk Range
1.192.68
Jw Cayman Therapeutics Co Ltd is currently considered to be trading at Fair valueExplore our list of undervalued stocks for hidden opportunities
Key Statistics
Edit
Bid/Ask
2.11 / 2.15
Prev. Close
2.3
Open
2.3
Day's Range
2.08-2.3
52 wk Range
1.19-2.68
Volume
2.44M
Average Volume (3m)
1.58M
1-Year Change
11.64%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2126 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
2.36
Upside
+11.77%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple
Show more

Jw Cayman Company Profile

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company’s pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.

Compare 2126 to Peers and Sector

Metrics to compare
2126
Peers
Sector
Relationship
P/E Ratio
−1.3x−8.9x−0.5x
PEG Ratio
−0.060.020.00
Price/Book
0.5x3.5x2.6x
Price / LTM Sales
4.6x11.3x3.0x
Upside (Analyst Target)
11.8%19.7%55.2%
Fair Value Upside
Unlock5.8%9.7%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.36
(+11.77% Upside)

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Jw Cayman (2126) Stock Price Today?

The Jw Cayman stock price today is 2.11.

What Stock Exchange Does Jw Cayman Trade On?

Jw Cayman is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Jw Cayman?

The stock symbol for Jw Cayman is "2126."

What Is the Jw Cayman Market Cap?

As of today, Jw Cayman market cap is 853.71M.

What is Jw Cayman Earnings Per Share?

The Jw Cayman EPS is -1.52.

From a Technical Analysis Perspective, Is 2126 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.